Colistin is an antibiotic of last resort for treating Gram-negative bacterial infections, but resistance is spreading rapidly. In a recent issue of Nature, Wang et al. use genome mining to identify and synthesize a natural variant that bypasses colistin resistance and offers new hope for tackling antimicrobial resistance.
|Number of pages||2|
|Journal||Cell Host & Microbe|
|Publication status||Published - 9 Mar 2022|
- anti-bacterial agents - pharmacology - therapeutic use
- drug resistance
- colistin - pharmacology - therapeutic use
- gram-negative bacterial Infections - drug therapy